We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

MK0752 in Treating Young Patients With Recurrent or Refractory CNS Cancer

This study has been terminated.
(This Phase I study was permanently closed to patient accrual on February 23, 2011, due to the discontinuation of support from MERCK.)
Sponsor:
ClinicalTrials.gov Identifier:
NCT00572182
First Posted: December 12, 2007
Last Update Posted: March 6, 2012
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborator:
National Cancer Institute (NCI)
Information provided by (Responsible Party):
Pediatric Brain Tumor Consortium
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: February 2011
  Primary Completion Date: February 2011 (Final data collection date for primary outcome measure)